[Immunological aspects of human retrovirus infection].
Kannagi
Mari
M
Department of Immunotherapeutics, Tokyo Medical and Dental University, Graduate School.
D016915:AIDS Vaccines; D000818:Animals; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology / Q000628:therapy; D015497:HIV-1; D015490:HTLV-I Infections / Q000276:immunology* / Q000635:transmission; D015368:Human T-lymphotropic virus 1 / Q000235:genetics / Q000276:immunology; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D009154:Mutation; D015493:Paraparesis, Tropical Spastic / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D019713:Receptors, CCR5 / Q000235:genetics; D012306:Risk
D016915:AIDS Vaccines; D019713:Receptors, CCR5